EP1882474 - Bibliographic data

PROPHYLACTIC/THERAPEUTIC AGENT FOR ABNORMALITIES OF LIPID METABOLISM

Last update 15/07/2025
Legal status Brevet déchu
Origin Euro-PCT

(73) Holder

MITSUBISHI TANABE PHARMA CORPORATION

2-6-18, Kitahama Chuo-ku Osaka-shi
Osaka 541-8505
Japon
(72) Inventors

ABE, Yuji

c/o MITSUBISHI TANABE PHARMA CORPORATION, 2-6-18, Kitahama,Chuo-ku , Osaka-shi
OSAKA 541-8505
Japon

KUSUNOKI, Aki

c/o MITSUBISHI TANABE PHARMA CORPORATION, 2-6-18,Kitahama, , Chuo-ku,Osaka-shi
OSAKA 541-8505
Japon

HAYASHI, Yoshiharu

c/o MITSUBISHI TANABE PHARMA CORPORATION, 2-6-18, Kitahama,Chuo-ku,Osaka-shi
OSAKA 541-8505
Japon

AKAHOSHI, Fumihiko

c/o MITSUBISHI TANABE PHARMA CORPORATION, 2-6-18, Kitahama, Chuo-ku, Osaka-shi
OSAKA 541-8505
Japon
(74) Agent

Mail recipient

VON KREISLER SELTING WERNER

Deichmannhaus am Dom Bahnhofsvorplatz 1
50667 Köln
Allemagne

(21) Request number EP06732351.9
(22) Request date 26/04/2006

(11) Publication number EP1882474
Publication date 03/11/2010

(54) Title of the invention PROPHYLACTIC/THERAPEUTIC AGENT FOR ABNORMALITIES OF LIPID METABOLISM
(51) International classification A61K 31/496A61P 3/06A61P 3/10C07D 417/14
International classification (before reform) None

Claimed priority

(31) Number: 2005127523
(32) Date: 26/04/2005
(33) Country: JP

Initial application None
Divisional application None

Expected annuity Annuity: 6 - Amount: 75 € - Due date 02/05/2011
Surtax: 6 - Amount: 15 € - Due date 03/11/2011
Last annuity None

Publication

BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2010/4, of 31/12/2010

History

Publication de la délivrance du brevet européen - Legal date 03/11/2010


Déchéance du brevet d'invention après période de grâce - Legal date 30/04/2011


Entrée en période de grâce du brevet d'invention - Legal date 02/05/2011